NHE-1: a promising target for novel anti-cancer therapeutics

Current Pharmaceutical Design
Ser Yue LooMarie Veronique Clement

Abstract

Among the many factors involved in the maintenance of homeostatic growth is the tight regulation of cellular pH. Intracellular pH of normal cells is maintained within a physiological range thanks to the activity of a number of pH regulators that respond to the acidbase shifts associated with normal cellular metabolic processes. Interestingly, there is a preponderance of evidence that dysregulation of intracellular pH is associated with processes that favor cell transformation such as cell cycle progression, enhanced proliferation, insensitivity to growth inhibitory stimuli, resistance to apoptosis, genomic instability and angiogenesis. Among the strategies employed by the cells to regulate intracellular pH, the Na⁺/H⁺ exchanger 1 (NHE1) protein from the Na⁺/H⁺ exchanger (NHE) family has been directly associated with cellular transformation, invasion and metastasis. These observations have heightened the interest in NHE1 as a promising novel drug target for more effective and selective anti-cancer therapeutics. Here we present a review of the basic biology of this remarkable protein and present evidence to support targeting NHE1 as a potential anti-cancer strategy.

Citations

Jan 11, 2013·The Journal of Biological Chemistry·Jun-Seok BaeKyungpyo Park
Feb 5, 2014·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Stephan Joel ReshkinRosa Angela Cardone
Jan 30, 2014·ELife·Cristina Paulino, Werner Kühlbrandt
Jun 12, 2013·Expert Opinion on Therapeutic Targets·Florian LangChristos Stournaras
Jun 21, 2015·Biochimie·Alison BesseAlyssa Carré-Mlouka
Dec 21, 2012·Chemical Biology & Drug Design·Joseph J Provost, Mark A Wallert
Dec 3, 2014·Biochimica Et Biophysica Acta·Enrico Pierluigi SpugniniStefano Fais
Jun 27, 2015·Nature Reviews. Drug Discovery·Lawrence LinKathleen M Giacomini
Jul 28, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Anita K BakraniaSnehal S Patel
Aug 17, 2016·International Journal of Cancer. Journal International Du Cancer·Jianling XiaWangjun Liao
Jul 30, 2016·Journal of Cellular and Molecular Medicine·Carlos SanhuezaLuis Sobrevia
Nov 20, 2019·Proteomics·Marie-Veronique Clement, Le Luo
Jul 21, 2020·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Wayne Taylor CottleJoseph John Provost
Apr 28, 2016·The Biochemical Journal·Yangzom D BhutiaVadivel Ganapathy
Feb 28, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Dumin YuanXuemei Liu
Aug 3, 2018·Nature Communications·David ShorthouseBenjamin A Hall
Feb 13, 2020·International Journal of Molecular Sciences·Salvador HarguindeyJesús Devesa
Feb 6, 2020·Frontiers in Physiology·Li CaoChristian Stock
Feb 9, 2013·Cancer Research·Schammim R Amith, Larry Fliegel
Sep 29, 2019·Biochemical and Biophysical Research Communications·Shin Young HyunJune-Won Cheong
May 8, 2021·Progress in Biophysics and Molecular Biology·Michael Levin
Aug 18, 2021·PLoS Computational Biology·Govindarajan SudhaArne Elofsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.